Elucid
Plaque-IQ™ is the only FDA-cleared CTA software that quantifies coronary and carotid plaque morphology using non-invasive CT scans. Request a demo.
Company Facts
Website
elucid.comAbout Elucid
Elucid has launched the AI-Predict study, an innovative international initiative aimed at redefining cardiovascular risk through a lesion-centric approach.
Where AI Leaders Stay Informed
The latest AI intelligence, case studies, and research — delivered to your inbox every week.
Free to read. Unsubscribe anytime.
Is this your company?
Claim this profile to manage information and unlock premium features.